Fasenra subcutaneous injection 30mg syringe (YJ code: 2290402G1020, standard: 30mg 1mL 1 tube) is an AstraZeneca medication containing Benralizumab (genetical recombination). It is indicated for add-on maintenance treatment of severe eosinophilic asthma in adults and children aged 6 years and older, and for eosinophilic granulomatosis with polyangiitis (EGPA) in adults.
Fasenra subcutaneous injection 30mg syringe
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).